Q3 FY2024 · Press release
2 pages
Read TScan Therapeutics, Inc.'s results firsthand
Preview this press release
Create a free account to start reading
Full documents are included with Professional
TScan Therapeutics, Inc.
NNASDAQ:TCRX0.18
USD
-0.03
(-13.43%)
